Clin2
NCT06672497Possibly a fitRecruiting

Testing a light sensor for muscle health in breast and gynecological cancer patients

Breast CancerGynecologic CancersMitochondrial Function

Part of Cancer, Skin clinical trials.

This study uses a safe, non-invasive light sensor (near-infrared spectroscopy) to measure how well your muscles use oxygen. Researchers want to learn if this tool can help monitor muscle health in people with breast or gynecological cancer that has not spread to other parts of the body.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
20 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with breast or gynecological cancer that has not spread to other parts of the body (no metastasis).
  • You are able to ride a stationary bike at a moderate pace for up to 15 minutes.
  • Your hemoglobin level (a protein in red blood cells that carries oxygen) must be above 10 at the start of the study.
  • Your liver function tests (ALT and AST) must be within a certain safe range (less than 2.5 times the upper limit of normal).
  • You are not very sedentary — you should have a score of 14 or higher on a short physical activity questionnaire.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07046936Recruiting
Mitochondria and resilience in gynecologic cancer

This study looks at how cell energy (mitochondria) relates to a person's ability to bounce back during treatment for advanced ovarian or endometrial cancer. If you qualify, you'll have tissue and blood samples analyzed alongside standard therapy to help find why some people handle treatment better than others.

Charlotte, North Carolina
NCT06976593Not yet recruiting
Muscle oxygen and function in breast cancer survivors

This trial measures how well your muscles use oxygen and how well you can perform daily activities after breast cancer treatment. It may help researchers understand how to improve recovery and physical function.

Badajoz
NCT04086329Recruiting· Phase 1
Testing an oxygen sensor during exercise in muscle disease

This early (Phase 1) study checks whether a tiny oxygen-sensing device works reliably while people with mitochondrial muscle disease (and some healthy volunteers) ride a stationary bike. The goal is to see if the sensor can measure oxygen use during exercise and help future monitoring or research.

Philadelphia, Pennsylvania
NCT06819683Recruiting· Phase 1
Testing a new oxygen sensor in people with and without mitochondrial myopathy

This study tests a tiny sensor that measures oxygen levels in muscle. It will help researchers understand how oxygen is used during exercise. If you have mitochondrial myopathy or are a healthy volunteer, you might be able to join.

Philadelphia, Pennsylvania
NCT07347535Not yet recruiting
Checking muscle oxygen in athletes and PAD patients

This study uses a special light-based imaging technique to measure muscle oxygen levels. It compares endurance athletes, strength athletes, healthy people, and patients with peripheral artery disease to see how muscles use oxygen.

NCT06438965Recruiting
Light test for muscle & nerve disease in kids

This study uses a safe, non-invasive light test (called MSOT) to help diagnose and monitor children with muscle or nerve diseases. It aims to find better ways to track these conditions without needles or radiation.

Ottawa, Ontario

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.